Results 121 to 130 of about 968 (157)
Development of a radiographic vertebral severity score for evaluation of disease progression in alkaptonuria. [PDF]
Rossignol F +11 more
europepmc +1 more source
Inborn Errors of Amino Acid Metabolism Revisited: Clinical Implications and Insights into Current Therapies. [PDF]
Shakerdi AL +3 more
europepmc +1 more source
The beta-triketone, nitisinone, kills insecticide-resistant mosquitoes through cuticular uptake
Stavrou-Dowd ZT +6 more
europepmc +1 more source
Integrating computational engines to identify <i>TSPAN6</i> as a migrasome-associated target for immunotherapy sensitization. [PDF]
Fang L, Pan H, Zhu Y.
europepmc +1 more source
Managing Alkaptonuria in Absence of Appropriate Medication: A Case Report and Review of Literature. [PDF]
Bhatti IA +5 more
europepmc +1 more source
Evaluation of Patients Diagnosed with Inherited Metabolic Diseases in Adulthood. [PDF]
Gulten ZA +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Role of Nitisinone in Tyrosine Pathway Disorders
Current Rheumatology Reports, 2014Nitisinone 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC), an effective herbicide, is the licensed treatment for the human condition, hereditary tyrosinaemia type 1 (HT-1). Its mode of action interrupts tyrosine metabolism through inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD).
Lakshminarayan Ranganath +1 more
exaly +3 more sources
Molecular Genetics and Metabolism
We conducted a systematic review to assess the efficacy and safety of nitisinone for the treatment of patients with alkaptonuria (AKU).Randomized clinical trials that assessed the impact of nitisinone on urinary and serum homogentisic acid (HGA), quality of life, joint range of motion, and adverse events in AKU patients were retrieved from Pubmed and ...
Flavia Diniz Mayrink, Camila Alves Areda
exaly +3 more sources
We conducted a systematic review to assess the efficacy and safety of nitisinone for the treatment of patients with alkaptonuria (AKU).Randomized clinical trials that assessed the impact of nitisinone on urinary and serum homogentisic acid (HGA), quality of life, joint range of motion, and adverse events in AKU patients were retrieved from Pubmed and ...
Flavia Diniz Mayrink, Camila Alves Areda
exaly +3 more sources

